Scleroderma: oral mycophenolate (ESUOM32)
Summary of the evidence on oral mycophenolate for systemic sclerosis (scleroderma) to inform local NHS planning and decision-making
Search results
6 results for occupational therapy
-
-
Mollii suit for spasticity (MIB100)
NICE has a developed medtech innovation briefing on Mollii suit for spasticity
-
Path Finder for freezing of gait in people with Parkinson's disease (MIB170)
NICE has developed a medtech innovation briefing (MIB) on RT300 for spinal cord injury rehabilitation
-
FLEXISEQ for osteoarthritis (MIB80)
NICE has developed a medtech innovation briefing (MIB) on FLEXISEQ for osteoarthritis
-
ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot (MIB56)
NICE has developed a medtech innovation briefing (MIB) on the ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot
-
QTUG for assessing falls risk and frailty (MIB73)
NICE has developed a medtech innovation briefing (MIB) on the Quantitative Timed Up and Go (QTUG)